Staar Surgical Announces Partnership with Actress Peyton List
Staar Surgical announced a partnership with actress and beauty entrepreneur, Peyton List, to promote the EVO Implantable Collamer Lenses (EVO), which recevied FDA approval in 2022 for the correction of myopia with or without astigmatism.
In December 2022, Ms. List had EVO lenses implanted by her doctor to put an end to her many years of personal vision frustrations such as torn contact lenses on set, irritating makeup-smudged contacts during her beauty routine, and forgotten glasses when she was on the road, according to Staar.
Ms. List, most recently known for her role in the Netflix series, Cobra Kai, has a new show on Paramount Plus, School Spirits. To better prepare and focus on her 2023, she decided to correct her distance vision by undergoing the EVO procedure, which involves adding a small, flexible lens in both eyes that doesn’t remove any cornea tissue.
“I’ve had problems with my vision longer than I haven’t. The worst is being in the middle of a day and feeling a contact lens rip and spending the rest of the day with one blurry eye,” Ms List said in a company news release. “After learning about vision correction options from my doctor, EVO was the most appealing because there is minimal down time, it does not cause dry eye syndrome and if I ever wanted to, the lenses are removable by my doctor for my added peace of mind.”
Ophthalmologist Neda Shamie, MD, who performed the EVO procedure for Ms. List, stated, “Peyton List was a dream patient of mine and now she has fantastic 20/20 vision thanks to the EVO lenses. Peyton was amazed at how quickly her vision improved after such little downtime and I am thrilled for her.”
Starting this month, a new EVO digital campaign entitled “A Pey in the Life,” will follow Ms. List throughout her EVO journey. Filmed at different moments, the videos show the ease of her EVO vision correction experience as well as the benefits she is now experiencing since the procedure in December 2022. In August 2022, Staar announced a partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO.
EVO lenses can permanently correct/reduce myopia with or without astigmatism without removing corneal tissue and, if desired, are removable by a doctor for added peace of mind. The EVO procedure involves implanting (or adding) a proprietary, biocompatible, flexible lens made from Collamer® into the eye between the iris (colored part of the eye) and the natural lens to correct/reduce nearsightedness with or without astigmatism. The EVO procedure takes about 20-30 minutes for each eye. The EVO lens works in harmony with the natural eye while delivering sharp, clear vision, excellent night vision, built-in UV protection, and does not induce dry eye syndrome. [2,3,4] Most patients experience improved vision right after the procedure.
For more information about EVO Implantable Collamer Lenses, visit https://EVOICL.com.
References:
1) | Holden B, Frick T, Wilson D et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 (Ophthalmology 2016;123:1036-1042). | |
2) | Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117–125. | |
3) | Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15. | |
4) | Naves, J. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012. | |
5) | Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology 2018: 12: 2427–2438. |